What is the appropriate management for a 58-year-old man with end-stage osteoarthritis of the right glenohumeral joint and shoulder pain who requests a mattress topper and a bed wedge, given he does not meet the Centurion guideline criteria for these devices?

Management of End-Stage Glenohumeral Osteoarthritis with Shoulder Pain

This patient with end-stage glenohumeral osteoarthritis and significant shoulder pain should be referred to orthopedic surgery for evaluation of total shoulder arthroplasty, as mattress toppers and bed wedges have no evidence-based role in treating glenohumeral osteoarthritis and do not address the underlying joint pathology causing his pain. 1

Why Mattress Toppers and Bed Wedges Are Not Indicated

• No evidence exists supporting mattress toppers or bed wedges as treatment modalities for glenohumeral osteoarthritis in any published guidelines or research. 2
• The AAOS guidelines comprehensively reviewed nonsurgical and surgical treatments for glenohumeral OA and made no mention of sleep surface modifications as therapeutic interventions. 2
• Treatment decisions for glenohumeral OA are driven by severity of symptoms (pain intensity and functional impairment), not by sleep positioning aids. 1

Evidence-Based Management for End-Stage Disease

Immediate Referral Indications

• Persistent shoulder pain despite conservative measures warrants orthopedic referral. 1
• Significant functional limitation interfering with activities of daily living or quality of life is an indication for surgical evaluation. 1
• At 58 years old with end-stage disease, this patient is an appropriate candidate for surgical intervention; chronologic age alone should not preclude surgical evaluation. 1

Appropriate Conservative Options (If Not Already Exhausted)

• Physical therapy targeting pain reduction, ROM improvement, and rotator cuff strengthening should be attempted if not already done. 3, 4
• NSAIDs are recommended as first-line pharmacological therapy for pain and inflammation reduction. 3, 4
• Intra-articular corticosteroid injections are widely used clinically, though evidence for their efficacy in glenohumeral OA is inconclusive (Grade I recommendation). 2
• Viscosupplementation (hyaluronic acid injections) is a weakly supported option that may provide temporary symptom relief (Grade C recommendation). 2, 1

Surgical Management for End-Stage Disease

• Total shoulder arthroplasty (TSA) is preferred over hemiarthroplasty for glenohumeral osteoarthritis, providing superior pain relief and lower revision rates (≈0% for primary TSA vs ≈14% revision of hemiarthroplasty). 1
• Both TSA and hemiarthroplasty produce significant improvements in pain, shoulder function, and overall quality of life. 2, 1
• Before proceeding with TSA, rotator cuff integrity must be confirmed, as an irreparable rotator cuff tear is a contraindication to anatomic TSA. 1

Critical Pitfalls to Avoid

• Do not delay orthopedic referral when symptoms are significant and radiographic disease is advanced (end-stage), as the condition will not improve spontaneously. 1
• Do not dismiss surgical options based on age alone; functional status and patient goals are more relevant than chronologic age. 1
• Do not approve non-evidence-based interventions (like mattress toppers or bed wedges) that lack any supporting data and divert resources from proven treatments. 2

Recommended Action Plan

1. Deny the request for mattress topper and bed wedge as they have no role in treating glenohumeral osteoarthritis. 2
2. Refer to orthopedic surgery for evaluation of total shoulder arthroplasty given end-stage disease. 1
3. Optimize medical management with NSAIDs and consider intra-articular injections (corticosteroid or viscosupplementation) for temporary relief while awaiting surgical consultation. 2, 1, 3
4. Ensure rotator cuff integrity assessment (via MRI or ultrasound) before surgical planning to determine appropriate arthroplasty type. 1